34
total announcements
524743.BO · 15 min delayed
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has appointed Mr. Chan Sing En as an Independent Director on the Board of Directors of FMV Global Innovations Pte. Ltd., a material wholly owned subsidiary company, with effect from October 27, 2026.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has dispatched a postal ballot notice to its shareholders on October 16, 2026, for approval of related party transactions and increase in borrowing limits. The notice is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Company has engaged National Securities Depository Limited (NSDL) to facilitate electronic voting.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance or rejection of securities received for dematerialisation during the quarter ended 30th September 2026.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd approved a Postal Ballot Notice and appointed a Scrutinizer for the e-voting process to obtain shareholder consent for Material Related Party transactions and increase in borrowing limits.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has announced the scrutinizer report and voting results for its 33rd Annual General Meeting (AGM) held on September 29, 2026, through video conferencing. All resolutions set out in the notice of the AGM were duly passed.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd held its 33rd Annual General Meeting (AGM) through video conferencing on September 29, 2026, with 61 members in attendance. The meeting was conducted in compliance with SEBI and MCA regulations, and the company's auditors and secretarial auditors were present. The AGM was attended by the company's directors, senior managerial personnel, and a representative of the statutory auditors.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has informed the exchanges about dividend declarations by its wholly-owned subsidiaries, Time Medical International Ventures (India) Private Limited and FlynnCare Health Innovations Private Limited, and an interim dividend declaration by FMV Global Innovation Pte Limited.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has issued a corrigendum to its Annual Report for FY 2025-26 to correct certain inadvertent errors/omissions. The corrections include minor errors in Financial Highlights and Key Financial Ratios, corrections in Independent Standalone and Consolidated Auditor's Report, and updates in Paid up Equity Share Capital and Financial Risk Management Objectives and Policies.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter ended September 30, 2026, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has approved the rights issue by its material unlisted subsidiaries and investment in equity shares of wholly owned material subsidiaries.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has released a Chairman's letter to shareholders, providing an overview of the company's business, key developments, and its outlook. The company has built a broader portfolio spanning point-of-care diagnostics, AI-enabled healthcare software, and end-to-end solutions company along with AI-driven drug discovery and portable wound-care technology.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has published a newspaper advertisement intimating shareholders that the Annual Report for FY 2025-26 will be sent through electronic mode and that the Annual General Meeting for 2026 will be conducted through Video Conferencing.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has announced the record date for e-voting and payment of dividend to shareholders. The register of members and share transfer books will be closed from September 23 to 29, 2026, for the annual general meeting scheduled on September 29, 2026. The cut-off date for determining shareholders entitled to receive the dispatch of notice of the 33rd annual general meeting is September 4, 2026.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has approved the appointment of Mr. David Yeow as an Additional Independent Director, reconstituted the Audit Committee, and scheduled its 33rd Annual General Meeting for September 29, 2026.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd's wholly owned subsidiary, Time Medical International Ventures (India) Private Ltd., launched the CLARION 64/128-Slice AI-Driven CT System in India at the India Health Expo 2026.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has announced that its step-down subsidiary, Time Medical Philippines, has been awarded a province-wide digital healthcare project for rollout across Catanduanes Province. The project combines Health Kiosks with the PhilHealth-accredited FlynnCare Clinic Management System (CMS) for dissemination. This marks an important milestone toward the digitalization of Universal Health Care in the Philippines.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Shankar Varadharajan & Others, indicating a significant acquisition of shares in the company.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has received a disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 for Shankar Varadharajan & PACs, indicating a significant acquisition of shares in the company.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating that Mr. Shankar Varadharajan and FMV Holdings Pte Ltd have acquired a significant stake in the company, with Mr. Varadharajan increasing his holding to 11.80% and FMV Holdings Pte Ltd increasing its holding to 51.20%.
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd has allotted 454,210 equity shares to FMV Holdings Pte Ltd, a promoter entity, upon conversion of warrants at an issue price of Rs. 23.40 per share.